Entrust Financial’s Organon & Co OGN Stock Holding History

Entrust Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60	Closed	-$359	–	458
2026 Q1	$359	Buy	60 +45	+300%	+$339	﹤0.01%	424
2025 Q4	$107	Buy	+15	New	+$119	﹤0.01%	417

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Entrust Financial's OGN Position: Q2 2026 in Review

Entrust Financial sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 60 shares — an estimated $359 sold.

Entrust Financial first reported a position in OGN in Q4 2025 and held it in 2 quarters. The position peaked at $359 in Q1 2026. 628 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Entrust Financial reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Entrust Financial sold 60 Organon & Co shares in Q2 2026, an estimated $359.
Entrust Financial first reported a position in Organon & Co in Q4 2025 and held it in 2 quarters.
Entrust Financial's Organon & Co position peaked at $359 in Q1 2026.
628 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.